Cambridge Biotechnology Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
25
- Latest Deal Type
-
M&A
- Investors
-
1
Cambridge Biotechnology General Information
Description
Developer of drugs designed for the treatment of clinical obesity. The company develops lead compounds for diseases with large medical needs using proprietary technologies.
Contact Information
Website
camb-biotech.comCorporate Office
- Building 250
- Babraham Research Campus
- Cambridge CB22 3AT
- England, United Kingdom
Corporate Office
- Building 250
- Babraham Research Campus
- Cambridge CB22 3AT
- England, United Kingdom
Cambridge Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 21-Mar-2005 | Completed | Product Development | |||
| 3. Early Stage VC | 30-Sep-2004 | Completed | Product Development | |||
| 2. Early Stage VC (Series A) | 01-Jul-2002 | $8.94M | $8.94M | Completed | Product Development | |
| 1. University Spin-Out | 01-May-2001 | Completed | Startup |
Cambridge Biotechnology Patents
Cambridge Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-0420615-D0 | Therapeutic compounds | Inactive | 16-Sep-2004 | ||
| GB-0420063-D0 | Therapeutic compounds | Inactive | 09-Sep-2004 | ||
| GB-0419718-D0 | Therapeutic compounds | Inactive | 06-Sep-2004 | ||
| GB-0413627-D0 | Analgesics | Inactive | 18-Jun-2004 | ||
| GB-0412259-D0 | Analgesics | Inactive | 02-Jun-2004 |
Cambridge Biotechnology Signals
Cambridge Biotechnology Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Avlar BioVentures | Venture Capital | Minority | ||
| Cambridge Gateway Fund | Venture Capital | Minority | ||
| Excalibur Group Holdings | Corporation | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| NVM Private Equity | PE/Buyout | Minority |
Cambridge Biotechnology FAQs
-
When was Cambridge Biotechnology founded?
Cambridge Biotechnology was founded in 2001.
-
Where is Cambridge Biotechnology headquartered?
Cambridge Biotechnology is headquartered in Cambridge, United Kingdom.
-
What is the size of Cambridge Biotechnology?
Cambridge Biotechnology has 25 total employees.
-
What industry is Cambridge Biotechnology in?
Cambridge Biotechnology’s primary industry is Drug Discovery.
-
Is Cambridge Biotechnology a private or public company?
Cambridge Biotechnology is a Private company.
-
What is Cambridge Biotechnology’s current revenue?
The current revenue for Cambridge Biotechnology is .
-
How much funding has Cambridge Biotechnology raised over time?
Cambridge Biotechnology has raised $15.8M.
-
Who are Cambridge Biotechnology’s investors?
Avlar BioVentures, Cambridge Gateway Fund, Excalibur Group Holdings, Johnson & Johnson JJDC, and NVM Private Equity have invested in Cambridge Biotechnology.
-
When was Cambridge Biotechnology acquired?
Cambridge Biotechnology was acquired on 21-Mar-2005.
-
Who acquired Cambridge Biotechnology?
Cambridge Biotechnology was acquired by Biovitrum.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process